A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Co Diagnostics, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 22,900 shares of CODX stock, worth $36,411. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22,900
Previous 73,800 68.97%
Holding current value
$36,411
Previous $98,000 74.49%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$1.06 - $1.42 $25,138 - $33,676
-23,716 Reduced 24.54%
72,931 $81,000
Q4 2023

Feb 14, 2024

BUY
$1.0 - $1.5 $24,372 - $36,558
24,372 Added 33.72%
96,647 $128,000
Q3 2023

Nov 14, 2023

BUY
$1.03 - $1.85 $17,294 - $31,063
16,791 Added 30.26%
72,275 $76,000
Q2 2023

Aug 14, 2023

BUY
$1.04 - $1.64 $23,192 - $36,572
22,300 Added 67.2%
55,484 $61,000
Q1 2023

May 15, 2023

BUY
$1.39 - $3.24 $14,387 - $33,537
10,351 Added 45.33%
33,184 $49,000
Q4 2022

Feb 14, 2023

BUY
$2.32 - $3.68 $52,972 - $84,025
22,833 New
22,833 $57,000
Q2 2022

Aug 15, 2022

BUY
$3.76 - $6.29 $148,790 - $248,907
39,572 Added 47.62%
122,673 $688,000
Q1 2022

May 16, 2022

BUY
$5.03 - $9.61 $41,517 - $79,320
8,254 Added 11.03%
83,101 $514,000
Q4 2021

Feb 14, 2022

SELL
$8.12 - $10.37 $372,837 - $476,148
-45,916 Reduced 38.02%
74,847 $668,000
Q3 2021

Nov 15, 2021

SELL
$7.48 - $11.38 $781,113 - $1.19 Million
-104,427 Reduced 46.37%
120,763 $1.18 Million
Q2 2021

Aug 16, 2021

BUY
$7.16 - $9.56 $782,702 - $1.05 Million
109,316 Added 94.34%
225,190 $1.86 Million
Q1 2021

May 17, 2021

BUY
$8.52 - $19.21 $723,952 - $1.63 Million
84,971 Added 274.96%
115,874 $1.11 Million
Q4 2020

Feb 16, 2021

SELL
$9.3 - $15.19 $174,207 - $284,539
-18,732 Reduced 37.74%
30,903 $287,000
Q3 2020

Nov 16, 2020

SELL
$8.24 - $30.8 $1.89 Million - $7.07 Million
-229,601 Reduced 82.22%
49,635 $675,000
Q2 2020

Aug 14, 2020

BUY
$7.46 - $23.42 $1.33 Million - $4.16 Million
177,777 Added 175.22%
279,236 $5.4 Million
Q1 2020

May 15, 2020

BUY
$0.91 - $17.81 $92,327 - $1.81 Million
101,459 New
101,459 $773,000
Q4 2019

Feb 14, 2020

SELL
$0.88 - $1.12 $17,951 - $22,846
-20,399 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$0.81 - $1.35 $2,337 - $3,896
-2,886 Reduced 12.39%
20,399 $21,000
Q4 2018

Feb 14, 2019

BUY
$1.15 - $2.61 $10,981 - $24,922
9,549 Added 69.52%
23,285 $34,000
Q3 2018

Nov 13, 2018

SELL
$2.63 - $4.24 $3,255 - $5,249
-1,238 Reduced 8.27%
13,736 $0
Q1 2018

May 11, 2018

BUY
$1.56 - $3.2 $23,359 - $47,916
14,974 New
14,974 $33,000

Others Institutions Holding CODX

About Co-Diagnostics, Inc.


  • Ticker CODX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 33,781,000
  • Market Cap $53.7M
  • Description
  • Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...
More about CODX
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.